Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CELC
CELC logo

CELC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Celcuity Inc (CELC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
122.460
1 Day change
-2.23%
52 Week Range
127.340
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Celcuity Inc (CELC) does not present a strong buy opportunity for a beginner, long-term investor at this time. While there are some positive technical indicators and analyst ratings, the lack of significant financial growth, insider selling, and absence of recent catalysts suggest a cautious approach. Holding the asset may be more appropriate until clearer growth signals emerge.

Technical Analysis

The technical indicators are moderately positive. The MACD is expanding positively at 1.14, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, RSI is neutral at 70.076, and the stock is trading near its resistance levels (R1: 125.479, R2: 129.761), which may limit immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios suggest bullish sentiment in the options market. However, the implied volatility percentile (13.2) and IV rank (3.83) indicate low volatility expectations, which may limit significant price movement.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • Analysts have raised price targets recently, with Craig-Hallum setting a target of $141, citing confidence in the company's pipeline progress and upcoming data readouts. Additionally, the stock has an 8.01% chance of increasing in the next month based on historical patterns.

Neutral/Negative Catalysts

  • Insider selling has increased significantly by 657.10% over the last month, which may indicate a lack of confidence from insiders. Financial performance remains weak, with no revenue growth and continued negative net income. There is also no recent news or significant event-driven catalysts to drive the stock higher.

Financial Performance

In Q4 2025, the company reported no revenue growth (0% YoY), a net loss of $50.97M (up 39.07% YoY), and an EPS of -0.97 (up 14.12% YoY). Despite some improvement in EPS and net income, the financials remain weak overall with no gross margin.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are generally positive, with multiple firms maintaining Buy ratings and raising price targets. Craig-Hallum raised the target to $141, Stifel to $125, and Needham to $122. However, the updates are largely based on pipeline progress and reduced expense estimates rather than immediate financial performance improvements.

Wall Street analysts forecast CELC stock price to fall
9 Analyst Rating
Wall Street analysts forecast CELC stock price to fall
8 Buy
1 Hold
0 Sell
Strong Buy
Current: 122.460
sliders
Low
94
Averages
106.5
High
126
Current: 122.460
sliders
Low
94
Averages
106.5
High
126
Craig-Hallum
Buy
maintain
$108 -> $141
AI Analysis
2026-03-26
Reason
Craig-Hallum
Price Target
$108 -> $141
AI Analysis
2026-03-26
maintain
Buy
Reason
Craig-Hallum raised the firm's price target on Celcuity to $141 from $108 and keeps a Buy rating on the shares following the Q4 update, which was largely in line and focused on pipeline progress. Management reiterated confidence in the wild-type NDA filing, which the firm shares given the strength of the data. Attention now shifts to the VIKTORIA-1 mutant cohort readout, now expected in Q2, with management declining to comment given proximity to data. Craig-Hallum views the timing as consistent with slower event accrual, similar to wild-type, which was the result of geda patients doing better.
Stifel
Stephen Willey
Buy
maintain
$115 -> $125
2026-03-26
Reason
Stifel
Stephen Willey
Price Target
$115 -> $125
2026-03-26
maintain
Buy
Reason
Stifel analyst Stephen Willey raised the firm's price target on Celcuity to $125 from $115 and keeps a Buy rating on the shares. The firm's updated target price primarily reflects reduced FY26 and later operating expense estimates, the analyst tells investors following the company's Q4 update.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CELC
Unlock Now

People Also Watch